Whats new
Whats new.
CLSA Equity Research - On the right pathway - Initiating coverage with a Buy Rating of A$1.19 TP (ASX:IMM) (Analyst: Andrew Paine)
October 16th 2021
For a copy of this research report please contact your CLSA advisor.
Whats new
October 16th 2021
For a copy of this research report please contact your CLSA advisor.